Open an account

Intuitive Surgical

ISRG · NASDAQ

$438.00+$4.82 (+1.11%)TodayMarket closed ·
Prev close $433.18

About ISRG

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Employees
17,021
Headquarters
Sunnyvale, California
Listed
Jun 13, 2000
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
intuitive.com

ISRG key statistics

Market cap
154.74B
Price-earnings ratio
49.68
Dividend yield
—
Average volume
1.97M
Volume
3.44M
Open price
$434.00
High today
$440.40
Low today
$432.00
52 Week high
$603.88
52 Week low
$328.57

Intuitive Surgical (ISRG) at a glance

Intuitive Surgical (ISRG) last traded at $438.00, with a market cap of 154.74B and a price-to-earnings ratio of 49.68.

Today the stock has traded between $432.00 and $440.40. The current price is 1.4% above the day's low and 0.5% below its high.

Volume so far is 3.44M shares, above the average of 1.97M shares a day.

Over the past year Intuitive Surgical has ranged from $328.57 to $603.88, and now sits 40% of the way up that range.

Intuitive Surgical met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q3 FY26 it reported $3.00 per share against an estimate of $2.70.

The average analyst price target is $490.39, 12.0% above the current price, from 27 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

81%of 27 analyst ratings say Buy
  • Buy81.5%
  • Hold18.5%
  • Sell0.0%
Price target · 33 analystsAvg $490.39
Low
$327.24
Now
$438.00
High
$719.25

ISRG earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 12.7% on average.

  1. Q4 FY24: reported $2.21 per share against an estimate of $1.83
  2. Q1 FY25: reported $1.81 per share against an estimate of $1.76
  3. Q2 FY25: reported $2.19 per share against an estimate of $1.96
  4. Q3 FY25: reported $2.40 per share against an estimate of $2.02
  5. Q4 FY25: reported $2.53 per share against an estimate of $2.30
  6. Q1 FY26: reported $2.50 per share against an estimate of $2.14
  7. Q2 FY26: reported $2.80 per share against an estimate of $2.55
  8. Q3 FY26: reported $3.00 per share against an estimate of $2.70

ISRG news

  • Intuitive Surgical Q3 2026 Earnings Call Transcript

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Adam Eckert

    Intuitive Surgical Tops Q3 Estimates, Shares Tumble

  • Kaustubh Bagalkote

    SpaceX Could Swing $128 Billion After Earnings

  • Press releaseGlobe Newswire

    The Next Big Thing Rarely Arrives on Schedule

  • Kaustubh Bagalkote

    Lam Research Could Swing $28.6 Billion After Earnings

  • 10 Health Care Stocks With Whale Alerts In Today’s Session

  • Surbhi Jain

    Move Over Tesla: Intuitive Surgical Shows Why Robotics Could Be Bigger Than Humanoids

Similar companies

Companies in the same industry as Intuitive Surgical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.